Bowel Cancer Clinical Trials
Colorectal Cancer
Learn More About Colorectal Cancer
For general information on colorectal cancer (including risk factors, symptoms, diagnosis, and treatment) visit the Cancer Council’s website:
General Enquiries
For general questions about trial availability, eligibility, or the referral process, please contact us using the form below. Our team will respond as soon as possible.
| Protocol Number | Cancer Type | Study Name | Intervention | Mechanism of Action | Recruitment Status | Sponsor | ClinicalTrials.gov ID | Click to Enquire |
|---|---|---|---|---|---|---|---|---|
| PTT-4256-01 | Colorectal Cancer | A Modular, Open Label, Dose Finding, Phase 1/2 Clinical Trial in Patients With Solid Tumours to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of PTT-4256. | Immunotherapy | Inhibitor of the pH-sensing G-protein-coupled receptor 65 | Open - Recruiting | Pathios Therapeutics Pty Ltd | NCT06634849 | Enquire Now |
| CP-IVX001 | Colorectal Cancer | A Phase 1 Open-label, Non-randomized, Multi-cohort Clinical Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours | Injectable Lesions | Ovarian, Gastric and CRC only. Must have Injectable lesions. Intratumoral injection. Live EchoVirus, No GMO component. | Open - Recruiting | ImmVirx PtyLtd | NCT05427487 | Enquire Now |
| HDM2017-101 | Colorectal Cancer | A Phase 1 Study of HDM2017 in Advanced Solid Tumors | Targeted | ADC targeting CDH17 conjugated to CPT-derivative payloads | Open - Recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | NCT07274085 | Enquire Now |